FOR sponsors & cros

Clinical trial sites in Australia: built for fast, human-centred delivery

Selecting the right site partner is critical to successful study delivery. For sponsors and CROs comparing the clinical trial sites Australia has to offer, UniSC Clinical Trials provides a connected network of six sites across South-East Queensland*. 
Our integrated model combines dedicated project management, strong recruitment capacity and transparent delivery from feasibility to close-out.
*The available R&D tax offset depends on company eligibility, expenditure and applicable company tax rate. Independent tax advice should be sought. Learn more on the ATO website.
Trusted by

Why sponsors and CROs choose our clinical trial sites in Australia

From established pharmaceutical organisations to emerging biotechnology companies, we support sponsors and CROs from Australia and overseas.

    300+

    clinical studies to date

    63 trials initiated in 2025

    97.6%

    Phase I retention rate

    Industry-leading performance

    <6 weeks

    Typical site start-up

    Site selection to site initiation

    6 clinical sites

    4M+ population catchment

    In South-East Queensland
oUR DIFFERENCE

Why sponsors choose UniSC Clinical Trials, again and again

We combine the governance and scientific expertise of a university with the agility of a purpose-built Australian clinical trial site network. Here is what that means for your study.

Dedicated clinical trial project management

Every trial at UniSC is assigned a dedicated project manager with CRO and sponsor backgrounds. Your PM is the single point of contact between your team, our sites, and all central services. That means faster decisions, fewer escalations, and no surprises.
8+
Strong PM team
PHD · MBA · PMP
Qualified backgrounds
50 years
Combined research experience in this team alone

The Australia advantage

R&D tax incentives, favourable exchange rates, GCP-compliant data accepted by FDA and EMA, and a multicultural population of 27M reflecting global target demographics. 1,200+ trials currently active, ~30% in Queensland.

Academic expertise, commercial mindset

University-backed scientific rigour with a results-driven commercial operation. 19 principal investigators. 150+ staff. FDA inspected 2024 with no findings. Life Sciences Queensland Company of the Year 2024.

Participant-centric design

Consumer Advisory Boards, patient experience surveys, and sentiment analysis built into every trial. Protocols aligned with patient needs from day one, reducing amendments, improving retention, and supporting commercial success.

Agile, transparent collaboration

Real-time project dashboards, proactive communication, and bespoke reporting. We adapt to your systems, not the other way around. Responsive, results-driven, and built for long-term partnership.
Let's collaborate together
what to expect

Clinical trial delivery from first conversation to last participant out

From feasibility and site activation to recruitment, retention and data delivery, our clinical trial sites follow a coordinated, sponsor-focused delivery model.
1

Feasibility & onboarding

Before you commit, we give you certainty. Protocol-specific feasibility assessments returned within 5 business days, covering site capability, investigator fit and realistic patient numbers. Dedicated specialists manage contracting and budgets, handing off to the activation team with everything in place.
2

Site activation

Site activation at UniSC Clinical trials is as little as six weeks. Dedicated start-up specialists drive ethics approvals, contracts and budgets in parallel. Your project manager is your single point of contact throughout, with clear reporting and proactive issue resolution at every step. Sites arrive at first patient fully prepared, fully staffed and ready to recruit from day one.
3

Recruitment & retention

We take a proactive, ethical, and performance-driven approach to recruitment and retention. Our dedicated staff implement targeted strategies, activate referral pathways, and provide real-time enrollment support. This patient-centered approach leads to stronger enrollment numbers, lower dropout rates, and reliable performance.
4

Data & delivery

Our data and delivery model is built around accountability. Dedicated leads assigned to each trial ensure rigorous data capture, protocol adherence and real-time oversight throughout the study. Proactive risk management keeps momentum on track, so you reach every milestone with clean data and full confidence in the outcome.
UniSC Clinical Trials in partnership with Alithia
"The efficient recruitment strategy from UniSC had allowed us to accelerate our studies momentum and reduce total study completion time. The team has been a great partner by being responsive, collaborative, and results-driven."
Alithia CRO company choose UniSC Clinical Trials as the main clinical trial sites in Australia for their study
Brad Stefanovic
Advisor, Clinical Operations (USA)· Alithia Life Sciences
Results that speak for themselves

Clinical trial delivery results and case studies

Real trials. Real outcomes. Here's what working with UniSC Clinical Trials looks like in practice.
Respiratory · Vaccines

SV + hMPV Vaccine Trial: enrolment closed 12 days early

A potential new vaccine for RSV and hMPV in people ≥60 years. UniSC CT sites reached 100% randomisation target ahead of schedule.
✓
2,660,505 campaign reach
✓
5.9% conversion rate from referral to screen
✓
Enrolment closed 12 days ahead of schedule
Women's Health · Phase I

Phase I Women's Health: dosing target exceeded by 133%

Engaged as a rescue site with strict eligibility criteria (premenopausal women 18–42). Site activated in 60 days to meet confinement schedule.
✓
285 women identified & pre-screened
✓
Dosing target exceeded by 133%
✓
Site activated in 60 days
Infectious Diseases

Longitudinal Chlamydia Study: 2,900% of randomisation goal

High-volume longitudinal study requiring consistent participant engagement over an extended period. UniSC CT delivered exceptional volume and engagement.
✓
3,381 referrals generated
✓
960 participants screened
✓
Achieved 29x initial randomisation target

Discuss your next clinical trial in Australia

Share your protocol, target population and delivery requirements. Our team will respond within one to two business days and begin a tailored feasibility assessment.
Or call us directly — +07 5409 8640 · Mon–Fri, 8am–5pm AEST
✓ Feasibility response within 5 days
✓ Start-up as fast as 6 weeks
✓ Dedicated PM from day one

Form submission notice

If you apply for a trial and receive an error message, don't worry, we have received your application. We’re working to resolve this now.

UniSC Clinical Trials South East Queensland
South East Queensland's most active clinical research network, connecting communities, clinicians and global sponsors since 2015.
Copywriting © 2026 UniSC Clinical Trials
envelopephone-handsetmap-marker
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram